Plasma collection and immunoglobulin manufacturing

This one pager describes the process of plasma collection and immunoglobulin manufacturing, explaining how the finished immunoglobin product used to treat hereditary angioedema (HAE) is first sourced from plasma from healthy donors, tested and screened for safety, then undergoes a series of fractionation, purification, and viral reduction/inactivation steps before being formulated for distribution.